Navigation Links
On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
Date:2/19/2008

ANN ARBOR, Mich., Feb. 19 /PRNewswire/ -- Compendia Bioscience, Inc. today announced results of a second productive year, including a renewed and expanding commitment from all major customers and the addition of several "Top 20" oncology drug companies to its customer roster. The new customers and existing customer commitment expansions led to a greater than 300% revenue increase, with similar growth forecasted for 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070213/NYTU093LOGO )

A key factor in Compendia's financial growth in 2007 was the mid-year release of Oncomine(TM) Concepts Edition, a unique analysis approach using drug and pathway signatures to help drug researchers and developers better understand a specific drug's biology and predict tumor populations likely to respond to the drug. Additionally, Compendia significantly expanded the Oncomine gene expression database in 2007 with cell line panels and drug perturbation studies, areas of specific interest for its customers.

"The addition of Oncomine Concepts Edition and targeted expansion of our data collection and curation efforts were key to our sales success last year, and multi-year commitments from customers have positioned us well for 2008 and beyond," said John Freshley, Compendia's Chief Business Officer. "We are particularly proud that we now count 12 of the top 20 oncology companies as our customers and are in active discussions with several more."

In addition, a major product milestone was completed in 2007 with the transition of the free academic offering from the University of Michigan to Compendia. With more than 15,000 user registrations, Oncomine has long been a leading tool for academic and non-profit researchers.

"This was a very significant step for Compendia," commented co-founder and CEO Dan Rhodes. "We have actively developed exciting new features for Oncomi
'/>"/>

SOURCE Compendia Bioscience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Spherix Reports Second Quarter Earnings
2. Tapestry Reports Second Quarter 2007 Results
3. Callisto Reports on Second-Quarter 2007 Milestones
4. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
11. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014  CryoLife, Inc. (NYSE: ... processing company focused on cardiac and vascular surgery, announced ... and Chief Executive Officer, has been elected to the ... Steven G. Anderson , Executive Chairman of ... proven to be an excellent leader who is well ...
(Date:10/22/2014)... 2014  Early symptoms of diabetic eye and ... new technology, coupled with yearly, comprehensive eye exams, ... detection of eye diseases, including those associated with ... left untreated, these diseases can potentially lead to ... Recently, optometric researchers have deployed a new tool ...
(Date:10/22/2014)... -- InVivo Therapeutics Holdings Corp. (OTCQB: NVIV) based in ... cord injury (SCI) treatment with their novel Neuro-Spinal Scaffold. ... regrowth in the spinal cord area when cells are ... polymer, the scaffold ultimately breaks down to water and ... NVIV has recently attracted significant investor attention with the ...
Breaking Medicine Technology:Pat Mackin Joins CryoLife Board of Directors 2Pat Mackin Joins CryoLife Board of Directors 3Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3
... HAIKOU, China , June 17 /PRNewswire-Asia/ -- Kun Run Biotechnology, ... in China focusing on manufacturing and sales of,peptide-based and small ... from the China State Food,and Drug Administration (SFDA). , ... Entecavir is an oral ...
... June 16 When 76-year old Cumming resident, ... the worst. Raised in the carnival and a self professed hobo ... addition to his other illnesses, Smith felt limited in his choices ... and Radiation Oncologist with Radiotherapy Centers of Georgia - ...
Cached Medicine Technology:Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration 2Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration 3Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration 4Cumming Radiation Oncologist Performs First Stereotactic Body Radiation Therapy in Forsyth County 2Cumming Radiation Oncologist Performs First Stereotactic Body Radiation Therapy in Forsyth County 3Cumming Radiation Oncologist Performs First Stereotactic Body Radiation Therapy in Forsyth County 4
(Date:10/22/2014)... 2014 (HealthDay News) -- Measures taken by Firestone officials ... Liberia may have limited the spread of the disease ... The Firestone Natural Rubber Co. provides health services to ... nearby densely populated communities. Between Aug. 1 and ... cases among those 80,000 people. That incidence rate of ...
(Date:10/22/2014)... By Dennis Thompson HealthDay ... freelance cameraman who was diagnosed with Ebola while working for ... system and can leave the special isolation unit at Nebraska Medical ... two weeks, the hospital said Tuesday. A blood test confirmed ... Ashoka Mukpo, 33, can head home to Providence, R.I., NBC ...
(Date:10/20/2014)... With a mere 19 days to ... a brief fundraising stop at the  Law Offices ... from a debate last night with his opponent Gov. ... the first seven minutes because Crist had an electric ... incident in one word: "weird." , Before touching on ...
(Date:10/20/2014)... The Advocator Group, LLC is ... Foundation for Suicide Prevention’s (AFSP) Out of the Darkness ... organization that hosts hundreds of community walks throughout the ... used to help understand and prevent suicide through not ... well. , The Advocator Group shares this passion ...
(Date:10/20/2014)... Columbus, OH (PRWEB) October 20, 2014 ... joined Specialists in Obstetrics & Gynecology of Columbus, Inc., ... specialized women’s healthcare services to more than 100,000 patients ... care though all ages and stages of a women’s ... office locations in Westerville and Dublin. , ...
Breaking Medicine News(10 mins):Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3
... Reporter , MONDAY, Sept. 13 (HealthDay News) -- The U.S. ... this week whether or not the diet drug Meridia should ... released Monday ahead of the panel meeting, which begins Wednesday, ... Drugs Advisory Committee will be asked to consider a number ...
... of the National Institutes of Health, announced today that ... Institutes in San Francisco, Calif., has been selected as ... HIV/AIDS Research for his proposal to study the mechanisms ... now in its third year, is intended to stimulate ...
... study describing a newly developed pharmacological inhibitor is providing ... implicated in multiple human malignancies regulates a known tumor ... September 14th issue of the journal Cancer Cell ... Mitogen-activated protein kinases (MAPKs) are enzymes that regulate ...
... that spurs the progression of non-small-cell lung cancer could become ... Southwestern Medical Center, who published a study on how the ... Cancer Cell . Scientists have known that the ... human tumors, including non-small-cell lung cancer (NSCLC). Until now, however, ...
... Earthy or musty odors, along with visual evidence of ... a warning that harmful cyanotoxins are present in lakes ... cyanobacterial blooms in Midwest lakes, taste-and-odor compounds were found ... serve as a warning that harmful toxins are present. ...
... findings from a major drug trial have brought experts a ... of British deaths from heart attacks. Dr Robert ... at Sheffield Teaching Hospitals, was the UK lead for international ... place over the last six years. The new findings ...
Cached Medicine News:Health News:FDA Panel to Mull Ban on Diet Drug Meridia 2Health News:FDA Panel to Mull Ban on Diet Drug Meridia 3Health News:Latent HIV infection focus of NIDA's 2010 Avant-Garde Award 2Health News:Selective inhibition of BMK1 suppresses tumor growth 2Health News:Lung cancer culprit could offer target for therapy, UT Southwestern researchers report 2Health News:If the water looks and smells bad, it may be toxic 2Health News:Breakthrough in drug trial offers hope for heart attack patients 2
... The Banana Split Splint reduces PIP joint ... design is easy to put on. Soft gel-lining ... finger can comfortably begin earlier for faster, more ... straighten the finger and at night to maintain ...
... FoamWrap Finger Trappers are ideal for use ... finger motion. Finger Trappers' non-slip foam lining ... the fingers in traction. These are truly ... Sold in packages of 5 and boxes ...
... stretch knee brace provides protection and added ... individuals with a history of joint instability. ... excellent side-to-side support, yet allow for free ... supports the entire knee area and helps ...
... Townsend Designs ROM post-operative knee braces ... facilitate progressive rehabilitation. , ,Adjustable and ... time-efficient choice for health care professionals. The ... ,ROM braces feature quick dial combination hinges ...
Medicine Products: